• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 Excel 和 ICD-10 的简单数据集计算器,用于计算 Charlson 和 Elixhauser 合并症指数。

Simple Excel and ICD-10 based dataset calculator for the Charlson and Elixhauser comorbidity indices.

机构信息

Department of Traumatology and Orthopaedics, University of Tartu, L. Puusepa 8, 50406, Tartu, Estonia.

Traumatology and Orthopaedics Clinic, Tartu University Hospital, L. Puusepa 8, 50406, Tartu, Estonia.

出版信息

BMC Med Res Methodol. 2022 Jan 7;22(1):4. doi: 10.1186/s12874-021-01492-7.

DOI:10.1186/s12874-021-01492-7
PMID:34996364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8742382/
Abstract

BACKGROUND

The Charlson and Elixhauser Comorbidity Indices are the most widely used comorbidity assessment methods in medical research. Both methods are adapted for use with the International Classification of Diseases, which 10th revision (ICD-10) is used by over a hundred countries in the world. Available Charlson and Elixhauser Comorbidity Index calculating methods are limited to a few applications with command-line user interfaces, all requiring specific programming language skills. This study aims to use Microsoft Excel to develop a non-programming and ICD-10 based dataset calculator for Charlson and Elixhauser Comorbidity Index and to validate its results with R- and SAS-based methods.

METHODS

The Excel-based dataset calculator was developed using the program's formulae, ICD-10 coding algorithms, and different weights of the Charlson and Elixhauser Comorbidity Index. Real, population-wide, nine-year spanning, index hip fracture data from the Estonian Health Insurance Fund was used for validating the calculator. The Excel-based calculator's output values and processing speed were compared to R- and SAS-based methods.

RESULTS

A total of 11,491 hip fracture patients' comorbidities were used for validating the Excel-based calculator. The Excel-based calculator's results were consistent, revealing no discrepancies, with R- and SAS-based methods while comparing 192,690 and 353,265 output values of Charlson and Elixhauser Comorbidity Index, respectively. The Excel-based calculator's processing speed was slower but differing only from a few seconds up to four minutes with datasets including 6250-200,000 patients.

CONCLUSIONS

This study proposes a novel, validated, and non-programming-based method for calculating Charlson and Elixhauser Comorbidity Index scores. As the comorbidity calculations can be conducted in Microsoft Excel's simple graphical point-and-click interface, the new method lowers the threshold for calculating these two widely used indices.

TRIAL REGISTRATION

retrospectively registered.

摘要

背景

Charlson 和 Elixhauser 合并症指数是医学研究中使用最广泛的合并症评估方法。这两种方法都适用于国际疾病分类,世界上有 100 多个国家使用第 10 次修订版(ICD-10)。现有的 Charlson 和 Elixhauser 合并症指数计算方法仅限于少数具有命令行用户界面的应用程序,所有这些都需要特定的编程语言技能。本研究旨在使用 Microsoft Excel 开发一种非编程和基于 ICD-10 的数据集计算器,用于计算 Charlson 和 Elixhauser 合并症指数,并使用基于 R 和 SAS 的方法验证其结果。

方法

使用该程序的公式、ICD-10 编码算法和 Charlson 和 Elixhauser 合并症指数的不同权重,开发了基于 Excel 的数据集计算器。使用来自爱沙尼亚健康保险基金的为期 9 年、跨越整个人群的真实索引髋部骨折数据对计算器进行验证。比较了基于 Excel 的计算器的输出值和处理速度与基于 R 和 SAS 的方法。

结果

共有 11491 例髋部骨折患者的合并症用于验证基于 Excel 的计算器。在比较 Charlson 和 Elixhauser 合并症指数的 192690 和 353265 个输出值时,基于 Excel 的计算器的结果与基于 R 和 SAS 的方法一致,没有差异。基于 Excel 的计算器的处理速度较慢,但仅相差几秒钟至四分钟,数据集中包括 6250-200000 名患者。

结论

本研究提出了一种新颖的、经过验证的、非编程的计算 Charlson 和 Elixhauser 合并症指数评分的方法。由于合并症计算可以在 Microsoft Excel 的简单图形点击界面中进行,因此新方法降低了计算这两个广泛使用的指数的门槛。

试验注册

回顾性注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f0/8742382/d4823338b5ad/12874_2021_1492_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f0/8742382/ea2a67f17795/12874_2021_1492_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f0/8742382/d4823338b5ad/12874_2021_1492_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f0/8742382/ea2a67f17795/12874_2021_1492_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f0/8742382/d4823338b5ad/12874_2021_1492_Fig2_HTML.jpg

相似文献

1
Simple Excel and ICD-10 based dataset calculator for the Charlson and Elixhauser comorbidity indices.基于 Excel 和 ICD-10 的简单数据集计算器,用于计算 Charlson 和 Elixhauser 合并症指数。
BMC Med Res Methodol. 2022 Jan 7;22(1):4. doi: 10.1186/s12874-021-01492-7.
2
New ICD-10 version of the Multipurpose Australian Comorbidity Scoring System outperformed Charlson and Elixhauser comorbidities in an older population.新版 ICD-10 版多功能澳大利亚共病评分系统在老年人群中优于 Charlson 和 Elixhauser 共病评分系统。
J Clin Epidemiol. 2016 Nov;79:62-69. doi: 10.1016/j.jclinepi.2016.04.004. Epub 2016 Apr 19.
3
Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10.验证 Charlson 和 Elixhauser 合并合并症指数在 ICD-9 和 ICD-10 中预测 30 天死亡率的有效性。
Med Care. 2018 May;56(5):441-447. doi: 10.1097/MLR.0000000000000905.
4
Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases.国际疾病分类第9版(ICD - 9)和第10版(ICD - 10)管理数据库中查尔森合并症和埃利克斯豪泽合并症的风险调整表现。
BMC Health Serv Res. 2008 Jan 14;8:12. doi: 10.1186/1472-6963-8-12.
5
Comparing Charlson and Elixhauser comorbidity indices with different weightings to predict in-hospital mortality: an analysis of national inpatient data.比较不同权重的 Charlson 和 Elixhauser 合并症指数对预测住院死亡率的效果:一项全国住院患者数据分析。
BMC Health Serv Res. 2021 Jan 6;21(1):13. doi: 10.1186/s12913-020-05999-5.
6
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.用于在ICD-9-CM和ICD-10管理数据中定义合并症的编码算法。
Med Care. 2005 Nov;43(11):1130-9. doi: 10.1097/01.mlr.0000182534.19832.83.
7
Development and Validation of the Summary Elixhauser Comorbidity Score for Use With ICD-10-CM-Coded Data Among Older Adults.老年人 ICD-10-CM 编码数据中 Summary Elixhauser 合并症评分的制定与验证。
Ann Intern Med. 2022 Oct;175(10):1423-1430. doi: 10.7326/M21-4204. Epub 2022 Sep 13.
8
Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality.比较不同的合并症衡量标准,用于预测短期和长期死亡率的行政数据。
BMC Health Serv Res. 2010 May 27;10:140. doi: 10.1186/1472-6963-10-140.
9
The ICD-10 Charlson Comorbidity Index predicted mortality but not resource utilization following hip fracture.ICD-10 Charlson 合并症指数可预测髋部骨折后的死亡率,但不能预测资源利用情况。
J Clin Epidemiol. 2015 Jan;68(1):44-51. doi: 10.1016/j.jclinepi.2014.09.017. Epub 2014 Oct 28.
10
Development and validation of a structured query language implementation of the Elixhauser comorbidity index.埃利克斯豪泽共病指数结构化查询语言实现方法的开发与验证
J Am Med Inform Assoc. 2017 Jul 1;24(4):845-850. doi: 10.1093/jamia/ocw181.

引用本文的文献

1
The impact of long-term trends in continuity of care on the medical expenses of hypertensive patients: based on group-based trajectory model.长期护理连续性趋势对高血压患者医疗费用的影响:基于群组轨迹模型
Front Public Health. 2025 Jul 30;13:1598324. doi: 10.3389/fpubh.2025.1598324. eCollection 2025.
2
The usefulness of Charlson Comorbidity Index (CCI) scoring in predicting all-cause mortality in Outpatients with Clinical Diagnoses of COPD.查尔森合并症指数(CCI)评分在预测慢性阻塞性肺疾病(COPD)临床诊断门诊患者全因死亡率方面的效用。
J Multimorb Comorb. 2025 Jan 27;15:26335565251315876. doi: 10.1177/26335565251315876. eCollection 2025 Jan-Dec.
3

本文引用的文献

1
Toolkit to Compute Time-Based Elixhauser Comorbidity Indices and Extension to Common Data Models.用于计算基于时间的埃利克斯豪泽共病指数及扩展到通用数据模型的工具包
Healthc Inform Res. 2020 Jul;26(3):193-200. doi: 10.4258/hir.2020.26.3.193. Epub 2020 Jul 31.
2
Coding algorithms for defining Charlson and Elixhauser co-morbidities in Read-coded databases.用于在 Read 编码数据库中定义 Charlson 和 Elixhauser 合并症的编码算法。
BMC Med Res Methodol. 2019 Jun 6;19(1):115. doi: 10.1186/s12874-019-0753-5.
3
Discriminative Ability for Adverse Outcomes After Surgical Management of Hip Fractures: A Comparison of the Charlson Comorbidity Index, Elixhauser Comorbidity Measure, and Modified Frailty Index.
Association of endovascular thrombectomy volume and outcomes in acute ischemic stroke: A National Inpatient Sample Study.
急性缺血性卒中血管内血栓切除术数量与预后的关联:一项全国住院患者样本研究。
Interv Neuroradiol. 2025 Jan 17:15910199241312524. doi: 10.1177/15910199241312524.
4
Comparison of Externally Transferred and Self-Recruited Patients with Hip and Knee Revision Arthroplasty at a Certified Maximum-Care Arthroplasty Center (ACmax).在一家认证的最高护理关节置换中心(ACmax)对髋关节和膝关节翻修置换术中外转患者和自招患者的比较。
Healthcare (Basel). 2024 Sep 18;12(18):1869. doi: 10.3390/healthcare12181869.
5
Adherence to Antibiotic Prescription Guidelines in Four Community Hospitals in Germany.德国四家社区医院对抗生素处方指南的遵循情况
Antibiotics (Basel). 2024 Jul 10;13(7):635. doi: 10.3390/antibiotics13070635.
6
Postoperative hand therapy and the 2018 Medicare therapy cap repeal: Appraising cost and use changes.术后手部治疗与2018年医疗保险治疗费用上限废除:评估成本及使用情况变化。
J Hand Ther. 2025 Jan-Mar;38(1):113-121. doi: 10.1016/j.jht.2024.05.002. Epub 2024 Jun 28.
7
Seven preoperative factors have strong predictive value for postoperative pneumonia in patients undergoing thoracoscopic lung cancer surgery.七个术前因素对接受胸腔镜肺癌手术的患者术后肺炎具有很强的预测价值。
Transl Lung Cancer Res. 2023 Nov 30;12(11):2193-2208. doi: 10.21037/tlcr-23-512. Epub 2023 Oct 7.
8
Symptoms, care consumption, and healthcare costs in hospitalized patients during the first wave of the COVID-19 pandemic.COVID-19 大流行第一波期间住院患者的症状、护理消耗和医疗保健费用。
PLoS One. 2023 Sep 14;18(9):e0291548. doi: 10.1371/journal.pone.0291548. eCollection 2023.
9
Effect of neoadjuvant chemotherapy on intraoperative core temperature in patients with breast cancer: a retrospective cohort study.新辅助化疗对乳腺癌患者术中核心体温的影响:一项回顾性队列研究。
BJA Open. 2022 Dec 31;5:100119. doi: 10.1016/j.bjao.2022.100119. eCollection 2023 Mar.
10
Prevalence and Risk Factors Associated with Potentially Inappropriate Prescribing According to STOPP-2 Criteria among Discharged Older Patients-An Observational Retrospective Study.根据STOPP-2标准,出院老年患者中潜在不适当处方的患病率及相关危险因素——一项观察性回顾性研究
Pharmaceuticals (Basel). 2023 Jun 7;16(6):852. doi: 10.3390/ph16060852.
髋部骨折手术治疗后不良结局的判别能力:Charlson合并症指数、Elixhauser合并症测量法和改良衰弱指数的比较
J Orthop Trauma. 2018 May;32(5):231-237. doi: 10.1097/BOT.0000000000001140.
4
The impact of comorbidities on hip fracture mortality: a retrospective population-based cohort study.合并症对髋部骨折死亡率的影响:一项基于人群的回顾性队列研究。
Arch Osteoporos. 2017 Aug 28;12(1):76. doi: 10.1007/s11657-017-0370-z.
5
Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data: The AHRQ Elixhauser Comorbidity Index.利用医院管理数据识别再入院和住院死亡率增加的风险:AHRQ埃利克斯豪泽共病指数
Med Care. 2017 Jul;55(7):698-705. doi: 10.1097/MLR.0000000000000735.
6
A new Elixhauser-based comorbidity summary measure to predict in-hospital mortality.一种基于埃利克斯豪泽方法的新的合并症综合测量指标,用于预测住院死亡率。
Med Care. 2015 Apr;53(4):374-9. doi: 10.1097/MLR.0000000000000326.
7
Systematic review of risk adjustment models of hospital length of stay (LOS).住院时间(LOS)风险调整模型的系统评价。
Med Care. 2015 Apr;53(4):355-65. doi: 10.1097/MLR.0000000000000317.
8
The Charlson comorbidity index can be used prospectively to identify patients who will incur high future costs.查尔森合并症指数可用于前瞻性地识别未来将产生高额费用的患者。
PLoS One. 2014 Dec 3;9(12):e112479. doi: 10.1371/journal.pone.0112479. eCollection 2014.
9
Predicting 30-day mortality following hip fracture surgery: evaluation of six risk prediction models.预测髋部骨折手术后30天死亡率:六种风险预测模型的评估
Injury. 2015 Feb;46(2):371-7. doi: 10.1016/j.injury.2014.11.004. Epub 2014 Nov 15.
10
The ICD-10 Charlson Comorbidity Index predicted mortality but not resource utilization following hip fracture.ICD-10 Charlson 合并症指数可预测髋部骨折后的死亡率,但不能预测资源利用情况。
J Clin Epidemiol. 2015 Jan;68(1):44-51. doi: 10.1016/j.jclinepi.2014.09.017. Epub 2014 Oct 28.